Experts Worry As Leading COVID-19 Vaccines Adopt Trial Shortcuts In "Rush For Results"
Operation Warp Speed: Are Bad Vaccine Trial Outcomes Good?
Political interference fears mount as Trump backs Pfizer’s COVID vaccine
Futures Rebound As Tech Gains; Powell, Mnuchin To Speak In Congress
Biocept's PCR Testing Remains a Key Piece of the COVID-19 Puzzle; Analyst Says 'Buy'
Teva Launches Two Digital Inhalers For Asthma Patients
New drug candidate found for hand, foot and mouth disease
CRISPR-based malaria testing on-the-fly
These 2 Penny Stocks Could Rally All the Way to $11, Says Cantor
SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication
Explainer: How clinical trials test COVID-19 vaccines
Pfizer Reveals Efficacy Criteria For Key Covid-19 Vaccine Trials
Illumina Confirms $8B Acquisition Of Cancer-Detection Firm Grail
Goldman Adds BJ’s Wholesale To Conviction Buy, Lifts PT
Global Stocks Plunge On Bank, Election, Virus Fears; Treasuries, Dollar Spike
EU regulators back uses for AZ’s Lynparza in prostate and ovarian cancer
AstraZeneca-Merck’s Lynparza Gets Recommended By EU For Prostate, Ovarian Cancers
AlloVir Gains 14% On FDA Trial Nod For Covid-19 Therapy
ATFX adds Merck & Co share CFDs to its offering
A DARPA-Funded Implantable Biochip To Detect COVID-19 Could Hit Markets By 2021
Is Pfizer Stock a Buy Right Now? This Is What You Need to Know
Wells Fargo: These 2 Stocks Could Deliver Triple-Digit Wins
Roche says a second trial of Actemra revives hopes for IL-6. What now?
Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial
Pfizer vaccine trial bets on early win against coronavirus, documents show
Silicon Valley startup Visby’s portable Covid-19 test gets FDA approval
Biden Joins FDA Critics, Seeks Independent Vaccine Review
CVS Health Gets A Buy Rating From Piper Sandler
3 "Strong Buy" Healthcare Stocks With Major Catalysts Approaching
Eli Lilly Strikes Deal With Amgen To Manufacture Covid-19 Antibody Therapies